16.40

5.30% 0.8396

Neogenomics Inc (NEO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NEO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$15.56

Aprire:

$15.86

Volume 24 ore:

597.44K

Relative Volume:

0.22

Capitalizzazione di mercato:

$2.14B

Reddito:

$745.97M

Utile/perdita netta:

$-99.21M

Rapporto P/E:

-21.22

EPS:

-0.7729

Flusso di cassa netto:

$-5.09M

1 W Prestazione:

+7.16%

1M Prestazione:

+13.00%

6M Prestazione:

+43.48%

1 anno Prestazione:

+184.46%

Intervallo 1D:

$15.86

$16.46

Intervallo di 1 settimana:

$15.34

$16.46

Portata 52W:

$5.63

$16.46

Neogenomics Inc Stock (NEO) Company Profile

Nome

Neogenomics Inc

Settore

Healthcare (1083)

Industria

Diagnostics & Research (49)

Telefono

(239) 768-0600

Indirizzo

9490 NEOGENOMICS WAY, FORT MYERS, FL

Dipendente

2,500

Cinguettio

@NeoGenomics

Prossima data di guadagno

2026-07-28

Ultimi documenti SEC

NEO's Discussions on Twitter

Compare NEO vs TMO, DHR, IDXX, NTRA, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NEO Neogenomics Inc	16.40	1.71B	745.97M	-99.21M	-5.09M	-0.7729
TMO Thermo Fisher Scientific Inc	587.20	207.93B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	203.73	138.14B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	588.06	43.87B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	317.92	36.95B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	145.10	38.94B	7.23B	1.41B	1.09B	4.979

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-30	Downgrade	BTIG Research	Buy → Neutral
2025-07-29	Downgrade	William Blair	Outperform → Mkt Perform
2025-05-15	Iniziato	Guggenheim	Neutral
2025-04-30	Downgrade	Leerink Partners	Outperform → Market Perform
2025-01-13	Downgrade	The Benchmark Company	Buy → Hold
2024-12-10	Iniziato	Jefferies	Buy
2024-05-01	Ripresa	Craig Hallum	Buy
2023-12-29	Reiterato	BTIG Research	Buy
2023-08-21	Aggiornamento	Stephens	Equal-Weight → Overweight
2023-05-16	Downgrade	Raymond James	Outperform → Mkt Perform
2023-05-09	Aggiornamento	BTIG Research	Neutral → Buy
2023-02-24	Aggiornamento	The Benchmark Company	Hold → Buy
2023-02-01	Aggiornamento	Needham	Hold → Buy
2022-08-26	Downgrade	The Benchmark Company	Buy → Hold
2022-08-22	Downgrade	Needham	Buy → Hold
2022-06-03	Iniziato	Piper Sandler	Overweight
2022-03-29	Downgrade	BofA Securities	Buy → Neutral
2022-03-29	Downgrade	Stephens	Overweight → Equal-Weight
2022-01-18	Ripresa	Stephens	Overweight
2021-12-16	Iniziato	Cowen	Outperform
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-10-14	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-06-03	Iniziato	Goldman	Buy
2021-02-25	Ripresa	Needham	Buy
2021-02-25	Downgrade	Raymond James	Outperform → Mkt Perform
2021-01-28	Iniziato	Truist	Buy
2020-12-11	Ripresa	BTIG Research	Buy
2020-10-28	Reiterato	Needham	Buy
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-08-28	Iniziato	Guggenheim	Buy
2020-07-29	Reiterato	Needham	Buy
2020-06-25	Iniziato	BofA/Merrill	Buy
2020-04-21	Ripresa	Stephens	Overweight
2020-03-02	Ripresa	Craig Hallum	Buy
2020-02-28	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2020-01-23	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-30	Reiterato	Needham	Buy
2019-05-01	Reiterato	Needham	Buy
2019-03-29	Reiterato	Needham	Buy
2019-01-03	Iniziato	Needham	Buy
2018-10-24	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2018-08-21	Iniziato	Leerink Partners	Outperform
2018-05-02	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-09-11	Downgrade	BTIG Research	Buy → Neutral
2017-08-24	Iniziato	Gabelli & Co	Buy
2016-12-15	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Neogenomics Inc Borsa (NEO) Ultime notizie

Jul 28, 2026

NeoGenomics (NEO) Is Down 7.7% After DOJ Settlement On Legacy Agreements – Has The Bull Case Changed? - simplywall.st

Jul 28, 2026

NeoGenomics in focus: Earnings test new diagnostic momentum By Investing.com - Investing.com South Africa

Jul 28, 2026

NeoGenomics pays $10 million to settle kickback allegations after self-disclosing below-market deals - Peoples Gazette Nigeria

Jul 28, 2026

Jul 27, 2026

NEO Balance Sheet - TradingKey

Jul 27, 2026

NEO|Neogenomics Inc|Price:13.890|Chg%:-0.350 - TradingKey

Jul 27, 2026

NEOUSD (NEOUSD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 27, 2026

NEO Income Statement - TradingKey

Jul 27, 2026

NEOUSD (NEOUSD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For - Yahoo! Finance Canada

Jul 27, 2026

NeoGenomics Laboratories to Pay $9.8 Million to Resolve FCA Allegations Relating to Below-Fair-Market-Value Consulting Services - ArentFox Schiff

Jul 27, 2026

Jul 26, 2026

Benchmark Co. Maintains NeoGenomics(NEO.US) With Buy Rating, Raises Target Price to $16 - Moomoo

Jul 24, 2026